Hiroshi Hongo

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

Journal: JCI insight
Published: January 14, 2025

Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4-CHOP axis.

Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4-CHOP axis.

Journal: Cancer science
Published: June 23, 2024

Concomitant Prostate Needle Biopsy and Laser Vaporization of the Prostate Could Be a Risk of Postoperative Hemoglobin Decline, a Retrospective Study.

Concomitant Prostate Needle Biopsy and Laser Vaporization of the Prostate Could Be a Risk of Postoperative Hemoglobin Decline, a Retrospective Study.

Journal: Research and reports in urology
Published: December 31, 2023

G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer.

G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer.

Journal: PNAS nexus
Published: July 10, 2023

Spontaneous ureterocele wall rupture by a ureteral stone: A case report.

Spontaneous ureterocele wall rupture by a ureteral stone: A case report.

Journal: Urology case reports
Published: December 11, 2022

The sialyl-Tn antigen synthase genes regulates migration-proliferation dichotomy in prostate cancer cells under hypoxia.

The sialyl-Tn antigen synthase genes regulates migration-proliferation dichotomy in prostate cancer cells under hypoxia.

Journal: Glycoconjugate journal
Published: September 30, 2022

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.

Journal: International journal of clinical oncology
Published: April 13, 2022

Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations.

Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations.

Journal: Cancer science
Published: March 22, 2022

Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan.

Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan.

Journal: BMJ open
Published: November 25, 2021

Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.

Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.

Journal: BMC medical genomics
Published: November 24, 2021

Salvage focal brachytherapy in castration-resistant prostate cancer with neuroendocrine differentiation after radiation therapy.

Salvage focal brachytherapy in castration-resistant prostate cancer with neuroendocrine differentiation after radiation therapy.

Journal: IJU case reports
Published: November 23, 2021

A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report.

A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report.

Journal: BMC medical genomics
Published: October 08, 2021
Showing 1-12 of 55

Last Updated: 09/26/2026